Cost Analysis of the Use of Glatiramer Acetate Compared to Interferon-Â in Patients with Relapsing-Remitting Multiple Sclerosis and Spasticity in Spain
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.876
https://www.valueinhealthjournal.com/article/S1098-3015(14)02806-X/fulltext
Title :
Cost Analysis of the Use of Glatiramer Acetate Compared to Interferon-Â in Patients with Relapsing-Remitting Multiple Sclerosis and Spasticity in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02806-X&doi=10.1016/j.jval.2014.08.876
First page :
A394
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
393